{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:40:05Z","timestamp":1771461605589,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1005445","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000}}],"reference-count":101,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL101200"],"award-info":[{"award-number":["R01HL101200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00HL093219"],"award-info":[{"award-number":["R00HL093219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["NDSEG Fellowship"],"award-info":[{"award-number":["NDSEG Fellowship"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000879","name":"Alfred P. Sloan Foundation","doi-asserted-by":"publisher","award":["Sloan Research Fellowship"],"award-info":[{"award-number":["Sloan Research Fellowship"]}],"id":[{"id":"10.13039\/100000879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005445","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T17:25:12Z","timestamp":1490030712000},"page":"e1005445","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-9341","authenticated-orcid":true,"given":"Lindsay E.","family":"Clegg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3481-7740","authenticated-orcid":true,"given":"Feilim","family":"Mac Gabhann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"ref1","article-title":"Systems biology of the microvasculature","author":"LE Clegg","year":"2015","journal-title":"Integrative Biology"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/wsbm.92","article-title":"Systems biology of pro-angiogenic therapies targeting the VEGF system","volume":"2","author":"F Mac Gabhann","year":"2010","journal-title":"Wiley Interdisciplinary Reviews-Systems Biology and Medicine"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/ten.teb.2009.0085","article-title":"Vascularization Strategies for Tissue Engineering","volume":"15","author":"M Lovett","year":"2009","journal-title":"Tissue Engineering Part B-Reviews"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-bioeng-071812-152428","article-title":"The Pivotal Role of Vascularization in Tissue Engineering","volume":"Vol 15","author":"FA Auger","year":"2013","journal-title":"Annual Review of Biomedical Engineering"},{"key":"ref5","article-title":"Extracellular Matrix-Inspired Growth Factor Delivery Systems for Skin Wound Healing","author":"PS Briquez","year":"2015","journal-title":"Advances in Wound Care"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.gene.2013.03.097","article-title":"Therapeutic angiogenesis for revascularization in peripheral artery disease","volume":"525","author":"A Grochot-Przeczek","year":"2013","journal-title":"Gene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1038\/natrevmats.2015.6","article-title":"Design principles for therapeutic angiogenic materials","volume":"1","author":"PS Briquez","year":"2016","journal-title":"Nature Reviews Materials"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/10739680802095964","article-title":"Systems biology of vascular endothelial growth factors","volume":"15","author":"F Mac Gabhann","year":"2008","journal-title":"Microcirculation (New York, NY: 1994)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20110301","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"437","author":"S Koch","year":"2011","journal-title":"Biochemical Journal"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal Transduction by Vascular Endothelial Growth Factor Receptors","volume":"2","author":"S Koch","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-01-328773","article-title":"Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output","volume":"118","author":"K Ballmer-Hofer","year":"2011","journal-title":"Blood"},{"issue":"24","key":"ref12","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.1074\/jbc.M909259199","article-title":"Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF","volume":"275","author":"Z Gluzman-Poltorak","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2013.11.002","article-title":"Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning","volume":"25","author":"P Vempati","year":"2014","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1091\/mbc.4.12.1317","article-title":"Vascular endothelial growth factor (VEGF) isoforms- Differential deposition into the subepithelial extracellular-matrix and bioactivity of extracellular matrix-bound VEGF","volume":"4","author":"JE Park","year":"1993","journal-title":"Molecular Biology of the Cell"},{"issue":"20","key":"ref15","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1101\/gad.242002","article-title":"Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis","volume":"16","author":"C Ruhrberg","year":"2002","journal-title":"Genes & Development"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1128\/MCB.20.19.7282-7291.2000","article-title":"Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature","volume":"20","author":"J Grunstein","year":"2000","journal-title":"Molecular and Cellular Biology"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.200409115","article-title":"Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors","volume":"169","author":"S Lee","year":"2005","journal-title":"Journal of Cell Biology"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/c1ib00037c","article-title":"VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF","volume":"3","author":"SM Anderson","year":"2011","journal-title":"Integrative Biology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1083\/jcb.200906044","article-title":"Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells","volume":"188","author":"TT Chen","year":"2010","journal-title":"Journal of Cell Biology"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"e1004158","DOI":"10.1371\/journal.pcbi.1004158","article-title":"Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model","volume":"11","author":"LW Clegg","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"P Carmeliet","year":"2001","journal-title":"Nature Medicine"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"S De Falco","year":"2012","journal-title":"Experimental and Molecular Medicine"},{"issue":"35","key":"ref23","doi-asserted-by":"crossref","first-page":"22272","DOI":"10.1074\/jbc.273.35.22272","article-title":"Neuropilin-1 is a placenta growth factor-2 receptor","volume":"273","author":"M Migdal","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0378(03)00082-2","article-title":"Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells","volume":"60","author":"W Yang","year":"2003","journal-title":"Journal of Reproductive Immunology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-642-59953-8_2","article-title":"Structure, expression and receptor-binding properties of placenta growth factor (PlGF)","volume":"237","author":"MG Persico","year":"1999","journal-title":"Vascular Growth Factors and Angiogenesis"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: A Multitasking Cytokine with Disease-Restricted Activity","volume":"2","author":"M Dewerchin","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","article-title":"Heterodimers of placenta growth factor vascular endothelial growth factor\u2014Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR","volume":"271","author":"YH Cao","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1535-6108(02)00028-4","article-title":"Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1\/VEGF heterodimers","volume":"1","author":"A Eriksson","year":"2002","journal-title":"Cancer Cell"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia","volume":"106","author":"A Reuvekamp","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1067\/mob.2000.108022","article-title":"Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia","volume":"183","author":"JC Livingston","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"RN Taylor","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"SE Maynard","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1034\/j.1600-0412.2003.00206.x","article-title":"Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels","volume":"82","author":"R Madazli","year":"2003","journal-title":"Acta Obstetricia Et Gynecologica Scandinavica"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences","volume":"88","author":"V Tsatsaris","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"RJ Levine","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.33549\/physiolres.930000.54.611","article-title":"Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women","volume":"54","author":"M Muy-Rivera","year":"2005","journal-title":"Physiological Research"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejogrb.2004.11.015","article-title":"Circulating concentrations of sFlt1 (soluble fins-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia","volume":"122","author":"AC Staff","year":"2005","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1081\/PRG-120028286","article-title":"Prospective analysis of placenta growth factor (PIGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia","volume":"23","author":"T Krauss","year":"2004","journal-title":"Hypertension in Pregnancy"},{"key":"ref39","first-page":"332","article-title":"Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential","volume":"11","author":"C D'Audigier","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-5-32","article-title":"Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins","volume":"5","author":"SE DePrimo","year":"2007","journal-title":"Journal of Translational Medicine"},{"issue":"10","key":"ref41","first-page":"A5","article-title":"Levels of placenta growth factor in gestational trophoblastic diseases","volume":"25","author":"T Okamoto","year":"2004","journal-title":"Placenta"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1042\/BST20110671","article-title":"An unexpected tail of VEGF and PlGF in pre-eclampsia","volume":"39","author":"DO Bates","year":"2011","journal-title":"Biochemical Society Transactions"},{"issue":"16","key":"ref43","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","article-title":"Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice","volume":"95","author":"S Hiratsuka","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"M Autiero","year":"2003","journal-title":"Nature Medicine"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00254.2003","article-title":"Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells","volume":"286","author":"F Mac Gabhann","year":"2004","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"H2851","DOI":"10.1152\/ajpheart.01218.2004","article-title":"Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model","volume":"288","author":"F Mac Gabhann","year":"2005","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00018-005-5426-3","article-title":"The role of VEGF receptors in angiogenesis; complex partnerships","volume":"63","author":"S Cebe-Suarez","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1006\/bbrc.1999.1580","article-title":"The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site","volume":"264","author":"M Park","year":"1999","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"17","key":"ref49","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1242\/jcs.00673","article-title":"Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin","volume":"116","author":"A Orecchia","year":"2003","journal-title":"Journal of Cell Science"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"RL Kendall","year":"1996","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"19","key":"ref51","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2016-04-711192","article-title":"Regulation of Vegf signaling by natural and synthetic ligands","volume":"128","author":"A Rossi","year":"2016","journal-title":"Blood"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-003-0776-3","article-title":"VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis","volume":"314","author":"M Tjwa","year":"2003","journal-title":"Cell and Tissue Research"},{"issue":"41","key":"ref53","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth-factor\u2014Potentiation of Vascular Endothelial Growth-Factor Bioactivity, in-vitro and in-vivo, and high-affinity binding to the FLT-1 but not to FLK-1\/KDR","volume":"269","author":"JE Park","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cmet.2016.03.004","article-title":"VEGFB\/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications","volume":"23","author":"MR Robciuc","year":"2016","journal-title":"Cell Metabolism"},{"issue":"0","key":"ref55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2015.06.002","article-title":"Molecular mechanism matters: Benefits of mechanistic computational models for drug development","volume":"99","author":"LE Clegg","year":"2015","journal-title":"Pharmacological Research"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-2-77","article-title":"A compartment model of VEGF distribution in blood, healthy and diseased tissues","volume":"2","author":"MO Stefanini","year":"2008","journal-title":"BMC Systems Biology"},{"issue":"4","key":"ref57","article-title":"A Compartment Model of VEGF Distribution in Humans in the Presence of Soluble VEGF Receptor-1 Acting as a Ligand Trap","volume":"4","author":"FTH Wu","year":"2009","journal-title":"Plos One"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"H2174","DOI":"10.1152\/ajpheart.00365.2009","article-title":"VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model","volume":"298","author":"FT Wu","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jnci\/djt093","article-title":"Effect of Tumor Microenvironment on Tumor VEGF During Anti-VEGF Treatment: Systems Biology Predictions","volume":"105","author":"SD Finley","year":"2013","journal-title":"Jnci-Journal of the National Cancer Institute"},{"issue":"23","key":"ref60","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1158\/0008-5472.CAN-10-1419","article-title":"Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model","volume":"70","author":"MO Stefanini","year":"2010","journal-title":"Cancer Research"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fonc.2013.00196","article-title":"Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice","volume":"3","author":"SD Finley","year":"2013","journal-title":"Frontiers in oncology"},{"issue":"11","key":"ref62","article-title":"A Two-Compartment Model of VEGF Distribution in the Mouse","volume":"6","author":"P Yen","year":"2011","journal-title":"Plos One"},{"issue":"7","key":"ref63","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.yexcr.2010.12.014","article-title":"Quantification and cell-to-cell variation of vascular endothelial growth factor receptors","volume":"317","author":"PI Imoukhuede","year":"2011","journal-title":"Experimental Cell Research"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/cam.5.4.17287","article-title":"Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions","volume":"5","author":"N Vintonenko","year":"2011","journal-title":"Cell Adhesion & Migration"},{"issue":"25","key":"ref65","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1074\/jbc.M113.451831","article-title":"Proteolytic Processing Regulates Placental Growth Factor Activities","volume":"288","author":"DC Hoffmann","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"6173","key":"ref66","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1247663","article-title":"Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing","volume":"343","author":"MM Martino","year":"2014","journal-title":"Science"},{"issue":"9","key":"ref67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044791","article-title":"Expression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle","volume":"7","author":"PI Imoukhuede","year":"2012","journal-title":"Plos One"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000357842","article-title":"Maternal Serum Placental Growth Factor (PIGF) Isoforms 1 and 2 at 11\u201313 Weeks&apos; Gestation in Normal and Pathological Pregnancies","volume":"36","author":"M Nucci","year":"2014","journal-title":"Fetal Diagnosis and Therapy"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D","article-title":"Differential expression of VEGF isoforms in mouse during development and in the adult","volume":"220","author":"YS Ng","year":"2001","journal-title":"Developmental Dynamics"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1582-4934.2009.00941.x","article-title":"A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use","volume":"14","author":"FTH Wu","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"35","key":"ref71","doi-asserted-by":"crossref","first-page":"26690","DOI":"10.1016\/S0021-9258(19)61431-6","article-title":"The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1","volume":"275","author":"G Fuh","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"33","key":"ref72","doi-asserted-by":"crossref","first-page":"24049","DOI":"10.1074\/jbc.M703554200","article-title":"Neuropilin-1 binds to VEGF(121) and regulates endothelial cell migration and sprouting","volume":"282","author":"Q Pan","year":"2007","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"ref73","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.18632\/oncotarget.2713","article-title":"Molecular architecture of the ErbB2 extracellular domain homodimer","volume":"6","author":"S Hu","year":"2015","journal-title":"Oncotarget"},{"issue":"5585","key":"ref74","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1074611","article-title":"Structure of the extracellular region of HER3 reveals an interdomain tether","volume":"297","author":"HS Cho","year":"2002","journal-title":"Science"},{"issue":"6924","key":"ref75","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab","volume":"421","author":"HS Cho","year":"2003","journal-title":"Nature"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1042\/BST0371193","article-title":"VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis","volume":"37","author":"AF Bruns","year":"2009","journal-title":"Biochemical Society Transactions"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.yexcr.2008.12.020","article-title":"VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent","volume":"315","author":"S Mittar","year":"2009","journal-title":"Experimental Cell Research"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1023\/B:ABME.0000030231.88326.78","article-title":"A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors","volume":"32","author":"RJ Filion","year":"2004","journal-title":"Annals of Biomedical Engineering"},{"issue":"1","key":"ref79","article-title":"Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle","volume":"292","author":"F Mac Gabhann","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"19","key":"ref80","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0021-9258(17)44280-3","article-title":"Reduced synthesis of basement-membrane heparan-sulfate proteoglycans in streptozotocin-induced diabetic mice","volume":"258","author":"DH Rohrbach","year":"1983","journal-title":"Journal of Biological Chemistry"},{"issue":"99","key":"ref81","article-title":"Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior","volume":"4","author":"H Yamamoto","year":"2016","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"5","key":"ref82","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/8379","article-title":"Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)","volume":"5","author":"P Carmeliet","year":"1999","journal-title":"Nature Medicine"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PlGF is arteriogenic\u2014Evidence for a monocyte-mediated mechanism","volume":"92","author":"F Pipp","year":"2003","journal-title":"Circulation Research"},{"issue":"2","key":"ref84","first-page":"537","article-title":"PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: Prognostic significance","volume":"23","author":"A Escudero-Esparza","year":"2010","journal-title":"Oncology Reports"},{"issue":"2","key":"ref85","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2353\/ajpath.2006.051041","article-title":"Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor","volume":"169","author":"M Marcellini","year":"2006","journal-title":"American Journal of Pathology"},{"issue":"12","key":"ref86","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1089\/hum.2005.16.1422","article-title":"Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A","volume":"16","author":"H Roy","year":"2005","journal-title":"Human Gene Therapy"},{"issue":"46","key":"ref87","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection","volume":"113","author":"M R\u00e4s\u00e4nen","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"ref88","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCRESAHA.107.160630","article-title":"Impaired angiogenesis after Hindlimb ischemia in type 2 diabetes Mellitus\u2014Differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1","volume":"101","author":"S Hazarika","year":"2007","journal-title":"Circulation Research"},{"issue":"100","key":"ref89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002614","article-title":"Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing","volume":"3","author":"MM Martino","year":"2011","journal-title":"Science Translational Medicine"},{"issue":"5","key":"ref90","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.devcel.2006.03.009","article-title":"Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis","volume":"10","author":"L Jakobsson","year":"2006","journal-title":"Developmental Cell"},{"issue":"6","key":"ref91","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.devcel.2014.02.010","article-title":"NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation","volume":"28","author":"S Koch","year":"2014","journal-title":"Developmental Cell"},{"issue":"6535","key":"ref92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM","volume":"376","author":"GH Fong","year":"1995","journal-title":"Nature"},{"issue":"3","key":"ref93","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)61775-0","article-title":"Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide","volume":"159","author":"B Bussolati","year":"2001","journal-title":"American Journal of Pathology"},{"issue":"12","key":"ref94","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/nm.3703","article-title":"An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease","volume":"20","author":"R Kikuchi","year":"2014","journal-title":"Nature Medicine"},{"issue":"13","key":"ref95","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCULATIONAHA.113.008171","article-title":"Antiangiogenic Actions of Vascular Endothelial Growth Factor-A(165)b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity","volume":"130","author":"DTM Ngo","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"ref96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011860","article-title":"Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model","volume":"5","author":"P Vempati","year":"2010","journal-title":"Plos One"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1752-0509-5-59","article-title":"Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis","volume":"5","author":"P Vempati","year":"2011","journal-title":"BMC Syst Biol"},{"issue":"1","key":"ref98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cvr\/cvw091","article-title":"Flt-1 (VEGFR-1) coordinates discrete stages of blood vessel formation","volume":"111","author":"JC Chappell","year":"2016","journal-title":"Cardiovascular Research"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fphys.2011.00062","article-title":"Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients","volume":"2","author":"YL Hashambhoy","year":"2011","journal-title":"Front Physiol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"H3740","DOI":"10.1152\/ajpheart.00009.2007","article-title":"Skeletal muscle VEGF gradients in peripheral arterial disease: Simulations of rest and exercise","volume":"293","author":"JW Ji","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref101","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-5-59","article-title":"Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis","volume":"5","author":"P Vempati","year":"2011","journal-title":"BMC Systems Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1005445","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T04:12:03Z","timestamp":1719115923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005445"}},"subtitle":[],"editor":[{"given":"Alison","family":"Marsden","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005445","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1005445","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}